TY - JOUR T1 - Association between COVID-19 mortality and population level health and socioeconomic indicators JF - medRxiv DO - 10.1101/2021.01.25.21250468 SP - 2021.01.25.21250468 AU - Sasikiran Kandula AU - Jeffrey Shaman Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/01/27/2021.01.25.21250468.abstract N2 - With the availability of multiple COVID-19 vaccines and the predicted shortages in supply for the near future, it is necessary to allocate vaccines in a manner that minimizes severe outcomes. To date, vaccination strategies in the US have focused on individual characteristics such as age and occupation. In this study, we assess the utility of population-level health and socioeconomic indicators as additional criteria for geographical allocation of vaccines. Using spatial autoregressive models, we demonstrate that 43% of the variability in COVID-19 mortality in US counties can be explained by health/socioeconomic factors, adjusting for case rates. Of the indicators considered, prevalence of chronic kidney disease and proportion of population living in nursing homes were found to have the strongest association. In the context of vaccine rollout globally, our findings indicate that national and subnational estimates of burden of disease could be useful for minimizing COVID-19 mortality.Competing Interest StatementJS and Columbia University declare partial ownership of SK Analytics. JS discloses consulting for BNI. SK consulted for SK Analytics.Funding StatementThis work is funded in part by the National Science Foundation (DMS-2027369), a gift from the Morris-Singer Foundation, and a National Institute for Environmental Health Science training grant (ES007322). The funders had no role in study design, analysis or decision to publish.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are publicly available and referenced in the manuscript. ER -